These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The development of a sensitive and specific enzyme immunoassay for FK480, a novel cholecystokinin type-A receptor antagonist, in human plasma. Nozaki K; Suzuki S; Maeda F; Takagaki S; Suzuki A; Hata T J Pharm Biomed Anal; 1998 Sep; 17(8):1381-92. PubMed ID: 9800657 [TBL] [Abstract][Full Text] [Related]
28. Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior. Clemens JA; Okimura T; Smalstig EB Arzneimittelforschung; 1993 Mar; 43(3):281-6. PubMed ID: 8489554 [TBL] [Abstract][Full Text] [Related]
29. Examination of cross-antigenicity of acetylcholinesterase and butyrylcholinesterase using anti-acetylcholinesterase antibodies. George KM; Montgomery MA; Sandoval LE; Thompson CM Toxicol Lett; 2002 Jan; 126(2):99-105. PubMed ID: 11751014 [TBL] [Abstract][Full Text] [Related]
30. Construction of a specific and sensitive sandwich enzyme immunoassay for 20 kDa human growth hormone. Hashimoto Y; Ikeda I; Ikeda M; Takahashi Y; Hosaka M; Uchida H; Kono N; Fukui H; Makino T; Honjo M J Immunol Methods; 1998 Dec; 221(1-2):77-85. PubMed ID: 9894899 [TBL] [Abstract][Full Text] [Related]
31. Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples. Stubenrauch K; Wessels U; Essig U; Kowalewsky F; Vogel R; Heinrich J J Pharm Biomed Anal; 2013 Jan; 72():208-15. PubMed ID: 23017233 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic study of harmane and its 10 metabolites in rat after intravenous and oral administration by UPLC-ESI-MS/MS. Li S; Teng L; Liu W; Cheng X; Jiang B; Wang Z; Wang CH Pharm Biol; 2016 Sep; 54(9):1768-81. PubMed ID: 26730489 [TBL] [Abstract][Full Text] [Related]
33. Sensitive method for the quantitative determination of bromocriptine in human plasma by liquid chromatography-tandem mass spectrometry. Salvador A; Dubreuil D; Denouel J; Millerioux L J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(2):237-42. PubMed ID: 15886074 [TBL] [Abstract][Full Text] [Related]
34. High affinity of ergopeptides for cytochromes P450 3A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine. Peyronneau MA; Delaforge M; Riviere R; Renaud JP; Mansuy D Eur J Biochem; 1994 Aug; 223(3):947-56. PubMed ID: 8055971 [TBL] [Abstract][Full Text] [Related]
35. Enzyme immunoassay of two nicergoline metabolites, 10 alpha-methoxy-9, 10-dihydrolysergol (MDL) and 1-methyl-10 alpha-methoxy-9, 10-dihydrolysergol (MMDL). Chen P; Tian Z; Digenis GA; Tai HH Res Commun Mol Pathol Pharmacol; 1996 Jun; 92(3):315-28. PubMed ID: 8827829 [TBL] [Abstract][Full Text] [Related]
36. Detection and interpretation of lysergic acid diethylamide results by immunoassay screening of urine in various testing groups. Wu AH; Feng YJ; Pajor A; Gornet TG; Wong SS; Forte E; Brown J J Anal Toxicol; 1997; 21(3):181-4. PubMed ID: 9171199 [TBL] [Abstract][Full Text] [Related]
37. Development of enzyme immunoassay for detection of DDT. Hirano M; Kitamura K; Kato I; Yanaihara C; Iwamoto K; Sekiyama M; Watanabe C; Nakamoto T; Miyamoto N; Onishi Y; Arizono K J Environ Sci Health B; 2008 Jan; 43(1):44-9. PubMed ID: 18161572 [TBL] [Abstract][Full Text] [Related]
38. Development of ultrasensitive enzyme immunoassay reviewed with emphasis on factors which limit the sensitivity. Ishikawa E; Hashida S; Kohno T Mol Cell Probes; 1991 Apr; 5(2):81-95. PubMed ID: 2072938 [TBL] [Abstract][Full Text] [Related]
39. Development and validation of sensitive sandwich ELISAs for two investigational nonapeptide metastin receptor agonists, TAK-448 and TAK-683. Yoshida N; Nishizawa N; Matsui H; Moriya Y; Kitada C; Asami T; Matsumoto H J Pharm Biomed Anal; 2012 Nov; 70():369-77. PubMed ID: 22748666 [TBL] [Abstract][Full Text] [Related]
40. Solid lipid nanoparticles as delivery systems for bromocriptine. Esposito E; Fantin M; Marti M; Drechsler M; Paccamiccio L; Mariani P; Sivieri E; Lain F; Menegatti E; Morari M; Cortesi R Pharm Res; 2008 Jul; 25(7):1521-30. PubMed ID: 18172580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]